YoheiDoiMD
Infectious Disease • Pittsburgh, PAAssistant Professor, Medicine, University of Pittsburgh School of Medicine
Are you Dr. Doi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# Falk
Pittsburgh, PA 15213Phone+1 412-648-6401Fax+1 412-648-6399
Summary
- Dr. Yohei Doi, MD is an infectious disease specialist in Pittsburgh, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with UPMC Presbyterian Shadyside and UPMC Magee-Womens Hospital.
Education & Training
UPMC Medical EducationFellowship, Infectious Disease, 2005 - 2008
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2003 - 2005
Nagoya University - School of MedicineClass of 1998
Certifications & Licensure
PA State Medical License 2005 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Gram Negative Bacteremia, Risk Factors for Failure of Therapy Start of enrollment: 2005 Apr 01
- Mechanisms of Resistance and Molecular Epidemiology of Commonly Encountered Multi-Resistant Bacteria Start of enrollment: 2006 Jan 01
- Community - Associated Extended-spectrum Beta-lactamases (ESBL) Start of enrollment: 2006 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 60 citationsIdentification of the ESKAPE pathogens by mass spectrometric analysis of microbial membrane glycolipids.Lisa M. Leung, William E. Fondrie, Yohei Doi, J. Kristie Johnson, Dudley K. Strickland
Scientific Reports. 2017-07-25 - 10 citationsReliability of serological tests for COVID-19: Comparison of three immunochromatography test kits for SARS-CoV-2 antibodiesHidetsugu Fujigaki, Masao Takemura, Michiko Osawa, Aki Sakurai, Kentaro Nakamoto
Heliyon. 2020-09-01 - 136 citationsA Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.Pranita D. Tamma, Yohei Doi, Robert A. Bonomo, J. Kristie Johnson, Patricia J. Simner
Clinical Infectious Diseases. 2019-09-27
Press Mentions
Fujita Health University Favipiravir Trial Evidences No Statistically Conclusive Benefit to COVID-19 Patients: A Question Mark for Favipiravir?July 11th, 2020- WHO Studies File International Each Day Coronavirus Circumstances Improve: LiveJuly 10th, 2020
No Pause in Coronavirus Trial for Avigan, Japan's Lead Researcher SaysMay 20th, 2020- Join now to see all
Grant Support
- Multidrug-Resistant Acinetobacter BaumanniiNational Institute Of Allergy And Infectious Diseases2009–2010
- Epidemiology Of Community-Associated, Esbl-Producing Escherichia ColiNational Institute Of Allergy And Infectious Diseases2009–2010
Professional Memberships
- Member
